COMP <GO>
ZEPP vs MSFT // FORWARD P/E MULTIPLE
Zepp Health Corporation each representing sixteen (Class A) (NYSE) VS. Microsoft Corporation (NASDAQ) • 15-METRIC TALLY: ZEPP 1
— MSFT 9
■ METRIC PARITY
LAST: $2.25 (-3.85%) • MKT CAP: $33.0M
forward-pe
—
LAST: $530.14 (-0.16%) • MKT CAP: $3.94T
forward-pe
24.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZEPP VS. MSFT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZEPP | MSFT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.30% | 67.66% | -29.36 | MSFT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -14.70% | 26.54% | -41.24 | MSFT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 19.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 1.55% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -11.30% | 47.10% | -58.40 | MSFT | /operating-margins <GO> |
| Net Profit Margin | -15.50% | 41.17% | -56.67 | MSFT | /net-margins <GO> |
| Revenue Growth (YoY) | 41.80% | 17.91% | +23.89 | ZEPP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.70% | -0.70 | MSFT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.33 | 9.35 | -9.02 | MSFT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | MSFT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 5.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 11.4 | 64.8 | -53.36 | MSFT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.14 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 24.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $33.0M | $3.94T | -$3.94T | MSFT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZEPP REV | MSFT REV | ZEPP GROSS % | MSFT GROSS % | ZEPP FCF | MSFT FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $331.84B | — | 67.9% | — | $66.99B |
| FY 2025 | $258.9M | $281.72B | 38.3% | 68.8% | -$26.2M | $71.61B |
| FY 2024 | $182.6M | $245.12B | 38.5% | 69.8% | -$25.8M | $74.07B |
| FY 2023 | $352.9M | $211.91B | — | 68.9% | $42.6M | $59.48B |
| FY 2022 | — | $198.27B | — | 68.4% | — | $65.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZEPP // BETA —
MSFT // BETA 1.14